If you need more lookups,
subscriptions start at $34 USD/month.
Ulf Andersson Location
Pully, VD, CH
Ulf Andersson Work
Head of Nonclinical Safety and DMPK @ (February 2025 - Present)
Head of Preclinical Safety @ (February 2022 - February 2025)
Senior Director, Head of CVRM Preclinical Safety @ (April 2019 - February 2022)
CVRM Safety Strategy Lead @ (January 2019 - April 2019)
Associate Director, Regulatory Safety @ (August 2015 - December 2018)
Principal Scientist and acting team leader, Discovery Safety @ (February 2014 - July 2015)
Project Toxicologist @ (August 2011 - February 2014)
Associate Research Fellow @ (December 2010 - May 2011)
Principal Scientist, Molecular Toxicology @ (October 2007 - November 2010)
Associate Principal Scientist @ (February 2004 - September 2007)
Senior Scientist @ Global Genomics AB (May 2002 - January 2004)
Senior Scientist @ Tripep AB (April 2001 - April 2002)
Ulf Andersson Education
Northwestern University
Post doc (Cell and molecular biology)
1998-2001
Stockholms universitet
Ph.D (Animal Physiology)
1992-1998
Stockholms universitet
B. Sc. (Molecular Biology)
1989-1992
Ulf Andersson Skills
Drug Discovery
Molecular Biology
Toxicology
Biochemistry
Physiology
Cell
DMPK
Drug Development
Drug Metabolism
Gene Expression Profiling
Inflammation
Lifesciences
Molecular Pharmacology
Pharmacokinetics
Pharmacology
In Vitro
Pharmaceutical Research
Ulf Andersson Summary
Ulf Andersson, based in Pully, VD, CH, is currently a Head of Nonclinical Safety and DMPK at Debiopharm. Ulf Andersson brings experience from previous roles at Debiopharm and AstraZeneca. Ulf Andersson holds a 1998 - 2001 Post doc in Cell and molecular biology @ Northwestern University. With a robust skill set that includes Drug Discovery, Molecular Biology, Toxicology, Biochemistry, Physiology and more. Ulf Andersson has 2 emails on RocketReach.
Looking for a different Ulf Andersson?
Find contact details for 700 million professionals.